A Few Simple Snarky Rules to Make Life Better
A Quick Bible Study Vol. 306: ‘Fear Not' Old Testament – Part 2
The War on Warring
No Sanctuary in the Sanctuary
Chromosomes Matter — and Women’s Sports Prove It
The Economy Will Decide Congress — If Republicans Actually Talk About It
The Real United States of America
These Athletes Are Getting Paid to Shame Their Own Country at the Olympics
WaPo CEO Resigns Days After Laying Off 300 Employees
Georgia's Jon Ossoff Says Trump Administration Imitates Rhetoric of 'History's Worst Regim...
U.S. Thwarts $4 Million Weapons Plot Aimed at Toppling South Sudan Government
Minnesota Mom, Daughter, and Relative Allegedly Stole $325k from SNAP
Michigan AG: Detroit Man Stole 12 Identities to Collect Over $400,000 in Public...
Does Maxine Waters Really Think Trump Will Be Bothered by Her Latest Tantrum?
Fifth Circuit Rules That Some Illegal Aliens Can Be Detained Without Bond Until...
Tipsheet

Two Countries Just Announced They're Halting Use of Moderna Vaccine for Younger Age Groups

AP Photo/Rogelio V. Solis

An unpublished Nordic study prompted Sweden and Denmark on Wednesday to announce a pause on the use of the Moderna vaccine in younger age groups.  

The study, which hasn’t been reviewed yet by the European Medicines Agency, raised concern over the risk of myocarditis and pericarditis in this demographic.

Advertisement

While the risk is small, "the connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose," the Swedish health agency said in a statement, Reuters reports. 

According to the agency, the risk was also more prevalent among young men and boys.

Denmark made the same “precautionary” call, though the Pfizer/BioNTech vaccine was already the primary option for those aged 12-17 in the country. 

"In the preliminary data ... there is a suspicion of an increased risk of heart inflammation, when vaccinated with Moderna," the Danish Health Authority said in a statement.

Both countries are now recommending the Pfizer jab for minors, which the EMA approved for use in May. Moderna’s Spikevax had been given the green light in July.

Advertisement

Related:

COVID-19 SWEDEN

In June, the U.S. FDA said it was adding a warning to both Pfizer and Moderna vaccines after a CDC advisory panel said data suggested a "likely association" between the vaccines and rare cases of myocarditis in adolescents and young adults. Despite the warning, doctors and researchers say they still strongly recommend that all Americans 12 and older get vaccinated, noting that the heart problems are uncommon and in most cases very mild.   

Two separate vaccine studies subsequently concluded, however, that COVID-19 itself poses a higher risk of symptoms, including heart inflammation, than the vaccines.  (CBS)

In the United States, only the Pfizer/BioNTech vaccine is authorized for use in minors. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement